CTATF vs EMR: Which Is the Better Dividend Stock?
As of Oct 8, 2026, EMR (Emerson Electric Co.) screens as the stronger dividend stock, winning 3 of 5 head-to-head metrics. EMR offers the higher yield at 1.39%, EMR has the higher dividend-safety score, and CTATF looks like the better value (its fair-value estimate is 32% below its share price).
Key facts: CTATF vs EMR
Data as of · Source: SmarterDividends data
- As of Oct 8, 2026, Emerson Electric Co. (EMR) has the higher forward dividend yield at 1.39%, versus 0.34% for Contemporary Amperex Technology Co., Limited (CTATF).
- By SmarterDividends' count as of Oct 8, 2026, CTATF has raised its dividend for 0 consecutive years and EMR for 53.
- As of Oct 8, 2026, CTATF's fair-value estimate is 32% below its share price and EMR's fair-value estimate is 53% below its share price, so CTATF looks like the better value of the two on SmarterDividends' blended model.
Cite this page
SmarterDividends, "CTATF vs EMR: Dividend Yield, Safety & Value Compared," updated Oct 8, 2026, https://smarterdividends.com/compare/ctatf-vs-emr
| Metric | CTATF | EMR |
|---|---|---|
| Forward yield | 0.34% | 1.39% |
| Annual dividend | $0.40 | $2.22 |
| Payout ratio | 0% | 48% |
| Years of growth | 0 yr | 53 yr |
| 5-yr dividend growth | — | 1.3% |
| 5-yr total return | — | 67% |
| Dividend safety score | — | 97 (A) |
| Fair value estimate | $42.20 | $74.46 |
| Upside to fair value | -32% | -53% |
| Frequency | annual | quarterly |
| Market cap | $285.1B | $89.2B |
| P/E ratio | 23.0 | 34.8 |
Higher yield
EMR
1.39%
Safer dividend
EMR
Grade A
Faster growth
EMR
1.3%
Better value
CTATF
-32% upside
CTATF vs EMR — FAQ
Is CTATF or EMR a better dividend stock?
On the data, EMR wins more head-to-head categories (3 vs 2). EMR offers the higher yield (1.39%), while EMR has the stronger dividend-safety score. The right pick depends on whether you prioritise income, safety or value.
Which has a higher dividend yield, CTATF or EMR?
EMR has the higher forward dividend yield at 1.39%, versus 0.34% for CTATF.
Is CTATF or EMR safer?
Compare each stock's payout ratio, growth streak and cut history on its detail page to judge safety.
Is CTATF or EMR better value right now?
As of Oct 8, 2026, CTATF looks like the better value: its fair-value estimate is 32% below its share price (overvalued). For EMR, its fair-value estimate is 53% below its share price.
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.